Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: A Novel Class of Potent Cytotoxins

被引:17
作者
Das, Swagatika [1 ]
Das, Umashankar [1 ]
Varela-Ramirez, Armando [2 ,3 ]
Lema, Carolina [2 ,3 ]
Aguilera, Renato J. [2 ,3 ]
Balzarini, Jan [4 ]
De Clercq, Erik [4 ]
Dimmock, Stephen G. [5 ]
Gorecki, Dennis K. J. [1 ]
Dimmock, Jonathan R. [1 ]
机构
[1] Univ Saskatchewan, Coll Pharm & Nutr, Drug Design & Discovery Res Grp, Saskatoon, SK S7N 5C9, Canada
[2] Univ Texas El Paso, Border Biomed Res Ctr, Cell Culture & High Throughput Screening Facil, El Paso, TX 79968 USA
[3] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA
[4] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[5] Nanyang Technol Univ, Dept Finance, Singapore 639798, Singapore
关键词
apoptosis; cytotoxic synergism; cytotoxicity; molecular modeling; unsaturated ketones; MANNICH-BASES; DESIGN; DISCOVERY;
D O I
10.1002/cmdc.201100199
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The principal objective of this study was the examination of the theory of cytotoxic synergism. In this exploratory study, we tested the hypothesis that doubling the number of sites available for thiol alkylation in a series of candidate cytotoxins increases potency more than two-fold. This concept was verified in one-third of our comparisons using human Molt 4/C8 and CEM T-lymphocytes and murine L1210 cells. In addition, the significant potencies of various members of our compound series justified further studies. Molecular modeling revealed that relative locations of the amidic groups correlate with cytotoxicity. A potent cytotoxic compound, 1,2-bis(3,5-dibenzylidene-4-oxo-piperidin-1-yl)ethane-1,2-dione (1a) inhibited the growth of a large number of human tumor cell lines and displayed greater toxicity toward certain non-adherent cells than toward adherent neoplasms or fibroblasts. The mode of action of 1a includes induction of apoptosis and necrosis.
引用
收藏
页码:1892 / 1899
页数:8
相关论文
共 26 条
[1]  
Aboul-Fadl T, 2000, Boll Chim Farm, V139, P228
[2]  
*ACD LABS, ACD LABS REL 10 00 V
[3]   Design, synthesis, and biological evaluation of hybrid molecules containing α-methylene-γ-butyrolactones and polypyrrole minor groove binders [J].
Baraldi, PG ;
Nunez, MD ;
Tabrizi, MA ;
De Clercq, E ;
Balzarini, J ;
Bermejo, J ;
Estévez, F ;
Romagnoli, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (11) :2877-2886
[4]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[5]  
Chen E.X., 2007, PRINCIPLES MED PHARM, P778
[6]   ROLE OF CELLULAR GLUTATHIONE AND GLUTATHIONE-S-TRANSFERASE IN THE EXPRESSION OF ALKYLATING AGENT CYTOTOXICITY IN HUMAN BREAST-CANCER CELLS [J].
CHEN, G ;
WAXMAN, DJ .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (06) :1079-1087
[7]   Novel Classes of Dimer Antitumour Drug Candidates [J].
Chow, Larry M. C. ;
Chan, Tak Hang .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (06) :659-674
[8]   3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and Related Diethyl Esters: Potent Cytotoxins with Multi-Drug-Resistance Reverting Properties [J].
Das, Swagatika ;
Das, Umashankar ;
Selvakumar, Ponniah ;
Sharma, Rajendra K. ;
Balzarini, Jan ;
De Clercq, Erik ;
Molnar, Joseph ;
Serly, Julianna ;
Barath, Zoltan ;
Schatte, Gabriele ;
Bandy, Brian ;
Gorecki, Dennis K. J. ;
Dimmock, Jonathan R. .
CHEMMEDCHEM, 2009, 4 (11) :1831-1840
[9]   Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds [J].
Das, Umashankar ;
Alcorn, Jane ;
Shrivastav, Anuraag ;
Sharma, Rajendra K. ;
De Clercq, Erik ;
Balzarini, Jan ;
Dimmock, Jonathan R. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (01) :71-80
[10]   3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: A lead tumor-specific cytotoxin which induces apoptosis and autophagy [J].
Das, Umashankar ;
Sakagami, Hiroshi ;
Chu, Qing ;
Wang, Qintao ;
Kawase, Masami ;
Selvakumar, Ponniah ;
Sharma, Rajendra K. ;
Dimmock, Jonathan R. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) :912-917